期刊
STEM CELL REPORTS
卷 11, 期 5, 页码 1120-1135出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2018.09.012
关键词
-
资金
- NSFC [31571407, 81373174, 81471832, 81671882, 81322012, 81770984]
- Hong Kong Research Grant Council General Research Fund [HKU17113816, HKU17120517]
- Science and Technology Foundation of Guangdong Province of China [2015B020225001]
- Natural Science Foundation of Guangdong Province [2014A030313051, 2016A030308017, 2017A030313105]
We previously identified an immunomodulatory role of human induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs) in asthmatic inflammation. Mitochondrial transfer from bone marrow MSCs to epithelial cells can result in the attenuation of acute lung injury in mice. However, the effects of mitochondrial transfer from iPSC-MSCs to epithelial cells in asthma and the mechanisms underlying these effects are unclear. We found that iPSC-MSC transplantation significantly reduced T helper 2 cytokines, attenuated the mitochondrial dysfunction of epithelial cells, and alleviated asthma inflammation in mice. Tunneling nanotubes (TNTs) were formed between iPSC-MSCs and epithelial cells, and mitochondrial transfer from iPSC-MSCs to epithelial cells via TNTs was observed both in vitro and in mice. Overexpression or silencing of connexin 43 (CX43) in iPSC-MSCs demonstrated that CX43 plays a critical role in the regulation of TNT formation by mediating mitochondrial transfer between iPSC-MSCs and epithelial cells. This study provides a therapeutic strategy for targeting asthma inflammation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据